Compare TMP & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMP | INMD |
|---|---|---|
| Founded | 1836 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 879.2M |
| IPO Year | N/A | 2019 |
| Metric | TMP | INMD |
|---|---|---|
| Price | $74.15 | $14.56 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $72.00 | $17.00 |
| AVG Volume (30 Days) | 53.7K | ★ 566.3K |
| Earning Date | 01-30-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | ★ 27.02 | 20.42 |
| EPS | ★ 5.90 | 2.21 |
| Revenue | $316,920,000.00 | ★ $364,494,000.00 |
| Revenue This Year | $16.28 | N/A |
| Revenue Next Year | $1.90 | $3.76 |
| P/E Ratio | $12.57 | ★ $6.57 |
| Revenue Growth | ★ 10.67 | N/A |
| 52 Week Low | $54.16 | $13.14 |
| 52 Week High | $78.30 | $19.78 |
| Indicator | TMP | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 67.17 | 53.62 |
| Support Level | $69.00 | $14.24 |
| Resistance Level | $72.51 | $14.58 |
| Average True Range (ATR) | 2.16 | 0.25 |
| MACD | 0.51 | 0.07 |
| Stochastic Oscillator | 80.62 | 91.41 |
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.